Incubators in intensive care environments can expose infants to a range of sounds, including alarms, equipment, conversations and other clinical activity. Image: Hengky/stock.adobe.com. The US Food and Drug Administration (FDA) has taken a step towards improving noise protection for premature and critically ill infants by formally classifying active noise attenuation systems designed for use in neonatal incubators....
Continue reading at Hearing Practitioner Australia
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change for most audiologists — this is a regulatory classification notice; NICU-focused audiologists and newborn hearing screening coordinators should monitor subsequent FDA performance standards and procurement implications for their hospitals.
FDA classification of incubator noise-cancelling systems formalises oversight of a neonatal hearing protection category, potentially driving adoption of evidence-based noise reduction in NICUs and reducing risk of noise-induced hearing damage in the most vulnerable patient population.
- 01The FDA has formally classified noise-cancelling systems for infant incubators as a medical device category.
- 02The move targets protection of neonates in intensive care from high noise levels produced by alarms and equipment.
- 03Regulatory classification paves the way for enforceable performance standards for these devices.
- 04This is a regulatory announcement — no clinical trial data or efficacy evidence accompanies the notice.
- 05Relevant primarily to NICU care teams, hospital procurement staff, and neonatal audiology specialists.
Infant incubators in intensive care expose neonates to harmful noise from alarms, equipment, and clinical activity.
guidelinesupportedFDA classification of noise-cancelling systems for infant incubators aims to improve noise protection for neonates.
press releasesupported
